More on Canada’s vaccine supply now, from the Guardian’s Michael Safi and Leyland Cecco:
Global health authorities have criticised countries for making private deals that they say push up vaccine prices and represent a form of “double-dipping” – taking supplies from Covax while at the same time signing private deals that make it harder for the facility to secure doses that would be shared equitably.
Other countries that have reserved significant supplies through side deals with pharmaceutical companies, including Australia, Israel and the UK, did not elect to receive or were not allocated any vaccine from the first batch of allocations announced on Wednesday.
Canada opted to receive 1,903,200 doses of the AstraZeneca vaccine through Covax, representing about 5% of its population – above the average that other countries will receive.
Canada and UK among countries with most vaccine doses ordered per personRead more
Some of the vaccine doses that Canada has reserved in private deals come from candidates that are still in development, and may not be approved. But taking into account just those that have released phase 3 results, Canada still has enough reserved to vaccinate its population at least four times over.
Chile and New Zealand, who have also made extensive private deals, were also both scheduled to receive enough vaccine through Covax over the next months to cover more than 5% of their people, the data showed.
In contrast, many of the countries that were allocated Covid-19 vaccine doses on Wednesday’s list have made no direct supply deals and have no other source of vaccinations but Covax: